Literature DB >> 12117861

Effect of partial compliance on cardiovascular medication effectiveness.

Joyce A Cramer1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12117861      PMCID： PMC1767238          DOI： 10.1136/heart.88.2.203

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

1.  Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence.

Authors:  J A Cramer
Journal:  Am J Manag Care       Date:  1998-11       Impact factor: 2.229

Review 2.  Enhancing patient compliance in the elderly. Role of packaging aids and monitoring.

Authors:  J A Cramer
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

3.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

4.  How to improve adherence with prescribed treatment in hypertensive patients?

Authors:  B Waeber; M Burnier; H R Brunner
Journal:  J Cardiovasc Pharmacol       Date:  2000       Impact factor: 3.105

5.  Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions.

Authors:  M Burnier; M P Schneider; A Chioléro; C L Stubi; H R Brunner
Journal:  J Hypertens       Date:  2001-02       Impact factor: 4.844

6.  A Study Design for Comparing the Effects of Missing Daily Doses of Antihypertensive Drugs.

Authors:  Brian F. Johnson; Andrew Whelton
Journal:  Am J Ther       Date:  1994-12       Impact factor: 2.688

7.  Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.

Authors:  R E Rangno; S Langlois
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Authors:  V Manninen; M O Elo; M H Frick; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

9.  Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Authors: 
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245

10.  The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers.

Authors:  B M Psaty; T D Koepsell; E H Wagner; J P LoGerfo; T S Inui
Journal:  JAMA       Date:  1990 Mar 23-30       Impact factor: 56.272
View more
  12 in total

Review 1.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 2.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

3.  Patient adherence to aromatase inhibitor treatment in the adjuvant setting.

Authors:  S Verma; Y Madarnas; S Sehdev; G Martin; J Bajcar
Journal:  Curr Oncol       Date:  2011-05       Impact factor: 3.677

Review 4.  Where are we with the management of hypertension? From science to clinical practice.

Authors:  Csaba Farsang; Lisa Naditch-Brule; Angelo Avogaro; Jan Ostergren; Paolo Verdecchia; Aldo Maggioni; Philippe van de Borne; Robert Lins; Alexandre Roca-Cusachs
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-02       Impact factor: 3.738

5.  Analysis of Factors Affecting Patients' Compliance to Topical Antiglaucoma Medications in Egypt as a Developing Country Model.

Authors:  Nahla B Abu Hussein; Iman M Eissa; Ahmed A Abdel-Kader
Journal:  J Ophthalmol       Date:  2015-06-17       Impact factor: 1.909

6.  [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].

Authors:  Hind El Aassri; Ghizlane El Mghari; Nawal El Ansari
Journal:  Pan Afr Med J       Date:  2014-03-13

7.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

8.  Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.

Authors:  Przemyslaw Kardas
Journal:  Vasc Health Risk Manag       Date:  2007

Review 9.  Challenges in the management of glaucoma in developing countries.

Authors:  Nadeem Hafeez Butt; Muhammad Hammad Ayub; Muhammad Hassaan Ali
Journal:  Taiwan J Ophthalmol       Date:  2016-04-20

10.  Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris.

Authors:  Yuri M Pozdnyakov
Journal:  Cardiol Ther       Date:  2018-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.